Effect of preemptive dexamethasone and etoricoxib on postoperative period following impacted third molar surgery - a randomized clinical trial

É-D Rodrigues, G-S Pereira, B-C Vasconcelos, R-C Ribeiro, É-D Rodrigues, G-S Pereira, B-C Vasconcelos, R-C Ribeiro

Abstract

Background: The aim of this study was to compare the anti-inflammatory effects of dexamethasone and etoricoxib after third molar extraction.

Material and methods: A prospective, randomized, controlled, split-mouth study was conducted. 19 volunteers were allocated randomly to receive 90mg etoricoxib 1 hour prior to the procedure or 4mg intramuscular dexamethasone immediately after anesthesia. Baseline measurements were obtained preoperatively, and subsequent assessments were made on immediate postoperative, at 72 hours and 7 days after surgery to measure postoperative facial swelling by use of linear measurements, interincisal mouth opening width and visual analog scale score for pain. The amount of analgesics consumed was recorded. Descriptive statistics and the independent-samples t-test were used to compare the two groups at P < 0.05.

Results: Dexamethasone was effective in the control roasted edema for measurements of the mandibular angle - wing of the nose and mandibular angle - labial commissure 72 hours after surgery. And for the measurement mandibular angle - mentum, in the time of 72 hours and 7 days. There was no statistically significant difference in relation to pain and trismus.

Conclusions: Considering significant results for some measures of the variable edema for the group that used intramuscular dexamethasone and the difference without statistical significance between groups for the other variables studied, we seem to reflect the intramuscular indication of the corticosteroid in a single dosage in relation to the use of etoricoxib as pre-emptive medication.

Conflict of interest statement

Conflicts of interest None of the authors have any competing interests in the manuscript.

Figures

Figure 1
Figure 1
Measurement of swelling.
Figure 2
Figure 2
Mean pain intensity at pre-operative, immediate post-operative, 72-hour and seven-day evaluations.
Figure 3
Figure 3
Boxplot of trismus at pre-operative, immediate post-operative, 72-hour and seven-day evaluations.

References

    1. Sotto-Maior BS, Senna PM, Assis NM. Corticosteroids or Cyclooxygenase 2-Selective Inhibitor Medication for the Management of Pain and Swelling After Third-Molar Surgery. J Craniofac Surg. 2011;22:758–62.
    1. Boonsiriseth K, Latt MM, Kiattavorncharoen S, Pairuchvej V, Wongsirichat N. Dexamethasone injection into the pterygomandibular space in lower third molar surgery. Int J Oral Maxillofac Surg. 2017;46:899–904.
    1. Chugh A, Singh S, Mittal Y, Chugh V. Submucosal injection of dexamethasone and methylprednisolone for the control of postoperative sequelae after third molar surgery: randomized controlled trial. Int J Oral Maxillofac Surg. 2018;47:228–33.
    1. Costa FWG, Soares ECS, Esses DFS, Silva PGDB, Bezerra TP, Scarparo HC. A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars. Int J Oral Maxillofac Surg. 2015;44:1166–74.
    1. Mojsa IM, Stypulkowska J, Novak P, Lipczynski K, Szczeklik K, Zaleska M. Pre-emptive analgesic effect of lornoxicam in mandibular third molar surgery : a prospective, clinical trial. Int J Oral Maxillofac Surg. 2017;46:614–20.
    1. Barbalho JC, Vasconcellos RJ, de Morais HH, Santos LA, Almeida RA, Rêbelo HL. Effects of co-administered dexamethasone and nimesulide on pain, swelling, and trismus following third molar surgery: a randomized, triple-blind, controlled clinical trial. Int J Oral Maxillofac Surg. 2017;46:236–42.
    1. Markovic A, Todorovic L. Effectiveness of dexamethasone and low-power laser in minimizing edema after third molar surgery. A clinical trial. Int J Oral Maxillofac Surg. 2007;36:226–9.
    1. Malmstrom K, Sapre A, Couglin H, Agrawal NG, Mazenko RS, Fricke JR. Etoricoxib in acute pain associated with dental surgery: A randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. Clin Ther. 2004;26:667–79.
    1. Brown JD, Daniels SE, Bandy DP, Ko AT, Gammaitoni A, Mehta A. Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain model. Clin J Pain. 2013;29:492–8.
    1. Neupert EA, Lee JW, Philput CB, Gordon JR. Evaluation of dexamethasone for reduction of postsurgical sequelae of third molar removal. J Oral Maxillofac Surg. 1992;50:1177–82.
    1. Laureano Filho JR, Maurette PE, Allais M, Cotinho M, Fernandes C. Clinical comparative study of the effectiveness of two dosages of Dexamethasone to control postoperative swelling, trismus and pain after the surgical extraction of mandibular impacted third molars. Med Oral Patol Oral Cir Bucal. 2008;13:129–32.
    1. da Costa Araujo FA, de Santana Santos T, de Morais HH, Laureano Filho JR, de Oliveira ESED, Vasconcellos RJ. Comparative analysis of preemptive analgesic effect of tramadol chlorhydrate and nimesulide following third molar surgery. J Craniomaxillofac Surg. 2012;40:e346–9.
    1. Malmstrom K, Kotey P, Coughlin H, Desjardins PJ. A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model. Clin J Pain. 2004;20:147–55.
    1. Savage MG, Henry MA. Preoperative nonsteroidal anti-inflammatory agents: review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:146–52.
    1. Lau SL, Chow RLK, Yeung RWK, Samman N. Pre-emptive ibuprofen arginate in third molar surgery: A double-blind randomized controlled crossover clinical trial. Aust Dent J. 2009;54:355–60.
    1. Barden J, Edwards JE, McQuay HJ, Moore RA. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain. 2004;107:86–90.
    1. Drew SJ. Best Practices for Management of Pain, Swelling, Nausea, and Vomiting in Dentoalveolar Surgery. Oral Maxillofac Surg Clin North Am. 2015;27:393–404.
    1. Alexander RE, Throndson RR. A review of perioperative corticosteroid use in dentoalveolar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:406–15.
    1. Mojsa IM, Pokrowiecki R, Lipczynski K, Czerwonka D, Szczeklik K, Zaleska M. Effect of submucosal dexamethasone injection on postoperative pain, oedema, and trismus following mandibular third molar surgery: a prospective, randomized, double-blind clinical trial. Int J Oral Maxillofac Surg. 2017;46:524–30.
    1. Antunes AA, Avelar RL, Martins Neto EC, Frota R, Dias E. Effect of two routes of administration of dexamethasone on pain, edema, and trismus in impacted lower third molar surgery. Oral Maxillofac Surg. 2011;15:217.
    1. Moore PA, Brar P, Smiga ER, Costello BJ. Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery. Oral Surg Oral Med Oral Pathol Radiol Endod. 2005;99:E1–7.
    1. Majid OW. Submucosal dexamethasone injection improves quality of life measures after third molar surgery: a comparative study. J Oral Maxillofac Surg. 2011;69:2289–97.
    1. Almeida RAC, Lemos CAA, De Moraes SLD, Pellizzer EP, Vasconcelos BC. Efficacy of corticosteroids versus placebo in impacted third molar surgery: systematic review and meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2019;48:118–31.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren